|
High $0.01 |
Low $0.01 |
Trades 62 |
Turnover $15,077 |
Volume 1,373,136 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (13-Nov) $70,159,808 (853rd) |
Close (30-Jun) $0.011 |
Volume (30-Jun) 1,373,136 |
Shortsold (6-Nov) 217 (0.00%) (685th) |
|
52w High $0.330 |
52w Low $0.055 |
P/E - |
EPS -0.01 |
U.S FDA Deprioritises EUA Application for CoviDx
LDX released this announcement to the ASX on 22 September 2021, 9:12. The announcement is marked as price sensitive, and is 2 page(s) in length and 156.2kb in size.
You can view all announcements from LDX and see how they appear on a price chart on the announcements page.
At the date of this announcement, LDX was 0.012% short sold according to ASIC data. It was ranked the 585th most shorted stock on the ASX. It remains ranked 685th as of the latest reported data (06 November 2026).
| Other Recent Announcements from LDX | |
|---|---|
| Change in substantial holding | 9 June 2023, 11:17 |
| Application for quotation of securities - LDX | 6 June 2023, 16:57 |
| Change in substantial holding from RYD | 6 June 2023, 16:32 |
| U.S FDA Deprioritises EUA Application for CoviDx | 22 September 2021, 9:12 |
| Change in substantial holding | 20 September 2021, 16:59 |
| Appointment of Dr. Jerome Adams as Strategic Health Adviser | 14 September 2021, 9:14 |
| Change in substantial holding | 1 September 2021, 15:48 |
If you were already registered, log in here.